SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $4,974,000 | +12.6% | 51,000 | +7.1% | 0.01% | +25.0% |
| Q4 2014 | $4,417,000 | +34.6% | 47,600 | -0.2% | 0.00% | +33.3% |
| Q3 2014 | $3,281,000 | -37.3% | 47,700 | -4.4% | 0.00% | -40.0% |
| Q2 2014 | $5,230,000 | +15.2% | 49,900 | -8.8% | 0.01% | 0.0% |
| Q1 2014 | $4,539,000 | +15.9% | 54,709 | -9.6% | 0.01% | +25.0% |
| Q4 2013 | $3,915,000 | -2.2% | 60,500 | -4.3% | 0.00% | -20.0% |
| Q3 2013 | $4,002,000 | +69.2% | 63,200 | +12.3% | 0.01% | +66.7% |
| Q2 2013 | $2,365,000 | – | 56,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,660,432 | $1,137,242,000 | 9.46% |
| BB BIOTECH AG | 1,025,476 | $100,015,000 | 2.98% |
| EMORY UNIVERSITY | 9,854 | $961,000 | 1.82% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,245,542 | $316,538,000 | 1.72% |
| New Leaf Venture Partners, L.L.C. | 24,379 | $2,378,000 | 1.61% |
| Alpha Wave Global, LP | 304,000 | $29,649,000 | 1.46% |
| Opus Point Partners Management, LLC | 17,700 | $1,726,000 | 1.45% |
| SECTORAL ASSET MANAGEMENT INC | 365,684 | $35,665,000 | 1.35% |
| Pier Capital, LLC | 61,028 | $5,952,000 | 0.90% |
| Tekla Capital Management LLC | 198,689 | $19,378,000 | 0.77% |